Reports July 2017

 

Cork Community Action on Alcohol North Side. (2017) Cork local action on alcohol plan 2016 – 2018. Cork: Cork Community Action on Alcohol North Side

Having participated in the National Community Action on Alcohol Pilot Programme in 2015, supported by the Alcohol Forum, the Cork Local & Southern Regional Drug & Alcohol Task Forces developed and launched its first Alcohol Strategy for Cork and Kerry in 2016 | CAN, Ireland

Alcohol treatment in Ireland: HRB publishes latest figures 

Latest alcohol treatment figures from the Health Research Board (HRB) show 56,702 cases were treated for problem alcohol use in Ireland between 2009 and 2015. Treated cases increased from 7,993 in 2009, to 8,876 in 2011, then decreased year-on-year to 7,616 in 2015 | HRB, Ireland

Childhood adversity, substance misuse and young people’s mental health (PDF)

Substance misuse is just one form of risk-taking behaviour, and can be a sign that young people are dealing with adversity, trauma, and/or experimenting with their identities | Addaction and Young Minds, UK

Stimulating and supporting a black and minority ethnic voice on drugs issues (PDF)

CityWide commissioned this paper to explore possible structures and processes through which to engage with, hear the voice of, and empower Black and minority ethnic communities in relation to issues of drug use | CityWide, Ireland

Fentanyl: a brief guide for first responders (PDF)

This document contains recommendations on potential best practices for first responders that may encounter, test and transport exhibits that could contain fentanyl‐related substances.   It also contains recommendations for handling and processing of crime scenes and non‐drug evidence, like money, that could be contaminated | DEA, USA

A performance measurement framework for drug and alcohol task forces

This study is about the development of a Performance Measurement Framework for the Drug and Alcohol Task Forces (DATF). The latter are community-based structures which bring together Government Departments, State Agencies and the Community and Voluntary sectors to provide a collective response to problem substance use | Trutz Haase – Social & Economic Consultants, Ireland

EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)

In November 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide, commonly known as furanylfentanyl, through a joint assessment | EMCDDA, Portugal

EMCDDA assessment of drug-induced death data and contextual information in selected countries

This report examines the triggers and dynamics of drug-related death in the seven EMCDDA Member States with the highest drug-related death (DRD) rates per population. The report explores whether between-country variations might be explained in part by differences in the number of drug users at risk of DRD, and by differences in the level of DRD risk among those who are at risk | EMCDDA, Portugal

Annual accounts 2016

These are the EMCDDA's final annual accounts for the financial year 2016 | EMCDDA, Portugal

It's Time for the U.S. to Decriminalize Drug Use and Possession

By any measure and every metric, the U.S. war on drugs — a constellation of laws and policies that seeks to prevent the use of certain drugs, primarily through punishment and coercion — has been a catastrophic failure | DPA, USA

Drug Strategy 2017

The drug strategy 2017 (PDF) sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes | Home Office, UK

Drug strategy 2016: development review

A review of the evidence on the 2016 drug strategy by the Advisory Council on the Misuse of Drugs (ACMD) | ACMD, UK

Updated drug misuse clinical guidelines published

The update to Drug Misuse and Dependence: UK guidelines on clinical management (often called the orange book) has been published. Last updated in 2007, the newly updated guidelines endorse much of the previous guidelines. But there is a stronger emphasis on recovery and on a holistic approach to the issues and interventions that can support recovery. Key additions and reinforced messages for 2017 include: incorporation of clinical guidance on prison-based treatment, new psychoactive substances and club drugs, mental health co-morbidity, misuse of prescribed and over-the-counter medicines, smoking cessation, and preventing drug-related deaths, including naloxone provision | PHE, UK

Psychoactive Substances Bill: evaluation review

An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD) | ACMD, UK

New report from Canada’s Drug Futures Forum outlines recommendations for the next decade of drug policy in Canada

Recommendations from a meeting of over 200 policymakers, public health officials, law enforcement professionals, researchers, people who use drugs, and community organizers provides an innovative roadmap to improve Canada’s policy response to illegal drugs over the coming ten years | Canada's Drug Futures Forum, Canada

New UNODC report: Coca crops in Colombia increase over 50 per cent in one year

he latest Colombia Cultivation Survey, produced by the Integrated System for Monitoring Illicit Crops (SIMCI) Project of UNODC, was released today, showing an increase of 52 per cent in coca cultivation area - from 96,000 hectares (ha) in 2015 to 146,000 ha in 2016 | UNODC, USA

Reducing Harm, Supporting Recovery 2017 – 2025

Ireland’s “Reducing Harm, Supporting Recovery” strategy sets out the Government’s response to addressing the harm caused by substance misuse in our society over the next eight years.  It identifies a set of key actions to be delivered between 2017 and 2020, and provides an opportunity for the development of further actions from 2021 to 2024 to address needs that may emerge later on in the lifetime of the strategy | Department of Health, Ireland

The drugs situation in Ireland: an overview of trends from 2005 to 2015 (PDF)

This report presents an overview of trends in the drugs situation in Ireland over a 10 year period. The report analyses the most recent data available with respect to the five European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) key indicators (prevalence of drug use, high risk drug use, treatment demand, drug-related deaths and mortality and drug-related infectious diseases) as well as drug-related crime and supply. Where data is available, trends under these six headings since 2005 are reported. In addition to presentation of national trends this reported includes additional evidence looking at trends in data relating to specific sub-populations including people who inject drugs, prisoners, homeless individuals, sex workers and the Travelling community | PHI, UK

HRB drug and alcohol evidence reviews (PDF)

This review examines the evidence on the effectiveness of interventions in the areas of harm reduction, prevention, treatment and long-term recovery related to illicit drug misuse and dependence | Health Research Board, Ireland

Drug-related intimidation. The Irish situation and international responses: an evidence review (PDF)

Drug-related intimidation is a pervasive and pressing issue negatively impacting the health and well-being of individuals, families, communities and the functioning of local agencies that serve them. The aim of this evidence review is to critically appraise the national and international evidence to identify best practice, community-based responses to DRI to inform: a) DRI action points within the upcoming National Drugs Strategy, 2017–2026, and b) Drugs Task Force action plans for implementing responses to DRI in their local communities | Health Research Board, Ireland

Ireland Thinks poll on attitudes to alcohol consumption Commissioned by Alcohol Action Ireland Conducted June 12th to June 16th 2017 (PDF)

A new opinion poll commissioned by Alcohol Health Alliance Ireland shows strong support for Government action to curb alcohol marketing that appeals to young people | Alcohol Action Ireland, Ireland

Budget 2017

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the Management Board, which may modify the draft before adopting it and submitting it to the European Commission. The Commission, in turn, makes its recommendations (which may again alter the draft) and presents the result to the European Council and Parliament | EMCDDA, Portugal

Albania, National Drug Report 2017

This report is prepared in the framework of the EMCDDA-IPA5 project ‘Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction’ funded by the European Commission. It provides a top-level overview of the drug phenomenon in Albania, covering drug supply, use and public health problems as well as drug policy and responses. It has been produced with the financial assistance of the European Union | EMCDDA, Portugal

Serbia, National Drug Report 2017

This report is prepared in the framework of the EMCDDA-IPA5 project ‘Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction’ funded by the European Commission. It provides a top-level overview of the drug phenomenon in Serbia, covering drug supply, use and public health problems as well as drug policy and responses. It has been produced with the financial assistance of the European Union | EMCDDA, Portugal

SAMHSA report shows the usage of non-medical pain relievers across the nation

A new report by the Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that 4.31 percent of people aged 12 or older in the U.S. used prescription pain relievers non-medically in the past year. When taken without a physician's direction, prescription opioid pain relievers can lead to a higher risk of serious adverse consequences such as substance use disorder, overdose, or death | SAMSHA, USA

Towards a smoke-free generation: tobacco control plan for England

Outlining plans to reduce smoking in England, with the aim of creating a smoke-free generation | DoH, UK

Cost of smoking to the NHS in England: 2015

Data on the cost of smoking to the NHS to support the development of the new Tobacco Control Plan for England | PHE, UK

Local alcohol consumption: national survey results

A summary of results from an alcohol consumption survey of 25 upper tier local authorities in England | PHE, UK

Smokefree Skills: An assessment of maternity workforce training

Time and again as this report was developed, stakeholders, midwives, obstetricians and others would agree that the issue of smoking in pregnancy was extremely important. The oft repeated phrase was that this importance “goes without saying”. This, it seems, is the crux of the problem | ASH, UK

Hepatitis C and people who inject drugs: The family experience

Today we are publishing our report “Marks and scars” on the impact of hepatitis C on the families of people who inject drugs | Adfam, UK

WHO report on the global tobacco epidemic 2017

The latest WHO report on the global tobacco epidemic published today finds that more countries have implemented tobacco control policies, ranging from graphic pack warnings and advertising bans to no smoking areas. About 4.7 billion people – 63% of the world’s population – are covered by at least one comprehensive tobacco control measure, which has quadrupled since 2007 when only 1 billion people and 15% of the world’s population were covered | WHO, Switzerland

Statistical bulletin: Crime in England and Wales: year ending Mar 2017

Drug offences in table 2 | ONS, UK

Mortality among a cohort of heavy drinkers in Edinburgh & Glasgow

This report represents secondary analysis of data derived from a study of the drinking characteristics of heavy drinkers in Scotland and supported financially by the Chief Scientist Office, Scotland (CZH/4/645) and Alcohol Research UK (R2011/01). Favourable ethical opinion was given by NHS Lothian Research Ethics committee (08/S1101/9) with additional approval from the Caldicott Guardians | SHAAP, Edinburgh Napier University, UK

More Australians dying of accidental overdose of pharmaceutical opioids

The rate of accidental deaths due to opioids is increasing and has more than doubled among Australians aged 35 to 44 since 2007 with more than two thirds of the deaths due to pharmaceutical opioids rather than heroin, a report from the National Drug and Alcohol Research Centre has found | NDARC, Australia

Financial case for action on liver disease (PDF)

Escalating costs of alcohol misuse, obesity and viral hepatitis | Foundation for Liver Research, UK

Alcohol labelling. A discussion document on policy options (PDF)

This discussion document presents an analysis of the policy options available for introducing warning and product labelling on alcoholic beverage containers. It outlines the existing legal and policy frameworks and the current level of implementation in the WHO European Region. Some components that could be considered when developing effective health warning labels are described | WHO, Denmark

EMCDDA–Europol 2016 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the key activities performed by the EMCDDA and Europol in 2016 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2016, Joint Reports produced, risk assessments conducted and public health-related alerts and advisories issued to the EU Early Warning System Network | EMCDDA, Portugal

Home Office Science non-departmental public bodies (NDPBs): triennial review

In April 2011, Cabinet Office announced that all NDPBs still in existence following the reforms brought about by the Public Bodies Act 2011 would have to undergo a substantive review at least once every 3 years | Home Office, UK

Alcohol labelling A discussion document on policy options (PDF)

This discussion document presents an analysis of the policy options available for introducing warning and product labelling on alcoholic beverage containers. It outlines the existing legal and policy frameworks and the current level of implementation in the WHO European Region. Some components that could be considered when developing effective health warning labels are described | WHO, Denmark

New analysis explains increase and inequality in drugs deaths

Today sees the release of new analysis which shows that the risk of drug-related deaths increased in Scotland from the 1990s for those born between 1960 and 1980, especially within deprived areas. [Media release (PDF)] | NHS Scotland, UK

Pregabalin: Guidance for people working with Pregabalin users (PDF)

This is primarily for people who work with people who use Pregabalin that is not prescribed to them. However it may also be useful to people who overuse their prescribed amount, people who take Pregabalin that isn’t prescribed for them or for people who care about a Pregabalin user. (If you are under 16 you should only use this booklet with support from a suitably qualified youth worker, social worker or addictions worker.) | Extern Supported by the Public Health Agency, Northern Ireland, UK

Drug misuse: findings from the 2016 to 2017 CSEW

Examines the extent and trends in illicit drug use among a sample of 16 to 59 year old residents in households in England and Wales | Home Office, UK

Practices and attitudes of General Practitioners in the delivery of Alcohol Brief Interventions in Scotland (PDF)

Our findings point to the fundamentally central role GPs play in responding to harmful and hazardous drinking through the delivery of ABIs in primary care. The study identified that facilitators for the effective delivery of ABIs fell into two categories, systemic factors and patient-centred factors | SHAAP, UK

Financial Incentives for Alcohol Brief Interventions in Primary Care in Scotland (PDF)

This study aimed to provide an overview of the evidence for using remuneration systems for Alcohol Brief Interventions (ABIs) in primary care, to examine the availability of relevant data in Scotland and to explore the views of local and national stakeholders | SHAAP, UK

EU Action Plan on Drugs 2017-2020

The use of illicit drugs and the misuse of drugs generally, is a major problem for individuals, families and communities across Europe. Apart from the health and social implications of drug misuse, the illicit drugs market constitutes a major element of criminal activity across European society and, indeed, on a global level | Eur-Lex, Belgium

People with co-occurring conditions: commission and provide services

Guidance on commissioning and providing better care for people with co-occurring mental health, and alcohol and drug use conditions | PHE, UK

New Report shows that Opioid Misuse Increases among Older Adults

A new spotlight report by the Department of Health and Human Services (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) indicates that opioid misuse among adults aged 50 or older in 2014 was higher than 2002. The misuse of opioids includes either the use of heroin or the nonmedical use of prescription pain relievers | SAMSHA, USA

National study highlights hidden causes of methamphetamine-related death

The number of methamphetamine-related deaths in Australia doubled between 2009 and 2015 with heart disease and violent suicide identified as prominent causes of death, a study from the National Drug and Alcohol Research Centre has found | NDARC, Australia

Guidance: Widening the availability of naloxone

Naloxone is the emergency antidote for overdoses caused by heroin and other opiates/opioids (such as methadone and morphine) | DoH et al, UK

Take-home naloxone for opioid overdose in people who use drugs (PDF)

Advice for local authorities and local partners on widening the availability of naloxone to reduce overdose deaths from heroin and other opiate drugs | PHE, UK

Unlinked anonymous HIV and viral hepatitis monitoring among PWID: 2017 report (PDF)

New data from the ongoing Unlinked Anonymous Monitoring Survey of HIV and Viral Hepatitis among People Who Inject Drugs (PWID) have been published on the PHE website | PHE, UK

 

 

 

 

Home : Terms of use : Contact
Copyright DrugWise©2016